表观遗传年龄与房颤发病风险
研究基于3个人群队列5600名参与者,评估4种表观遗传时钟及DNAm PAI-1预测因子与房颤发病的关联。校正年龄、种族、性别和吸烟后,DNAm GrimAge和DNAm PhenoAge的加速与房颤风险增加相关,但孟德尔随机化未显示显著因果关联。
要点
- 表观遗传年龄加速(EAA)与房颤发病风险独立于实足年龄相关。
- DNAm GrimAge每5年增加与房颤风险增加19%相关,DNAm PhenoAge为15%。
- 孟德尔随机化分析未支持EAA与房颤的因果关联,需进一步研究。
核心结论
- 表观遗传年龄加速指标与房颤发病风险存在调整后关联,提示生物学衰老独立于实足年龄起作用。
- 潜在因果关联尚不明确,孟德尔随机化分析未发现显著关联。
研究设计与样本
- 来自3个人群队列的5600名参与者,平均年龄65.5岁,女性占60.1%,黑人占50.7%。
- 平均随访12.9年,发生905例房颤。
- 评估4种表观遗传时钟(Horvath、Hannum、DNAm PhenoAge、DNAm GrimAge)及DNAm PAI-1预测因子。
- 采用Cox模型和随机效应荟萃分析,并进行两样本汇总水平孟德尔随机化分析。
主要发现
- 未校正分析中,所有4种表观遗传时钟和DNAm PAI-1均与房颤风险增加显著相关,但效应量小于实足年龄的关联。
- 校正年龄、种族、性别和吸烟后,除Horvath EAA外,其他EAA指标与房颤风险相关。
- 进一步校正其他房颤危险因素后,DNAm GrimAge和DNAm PhenoAge的EAA仍显著。
- DNAm GrimAge每5年增加与房颤风险增加19%相关(校正HR 1.19,95%CI 1.09-1.31,P<0.01)。
- DNAm PhenoAge每5年增加与房颤风险增加15%相关(校正HR 1.15,95%CI 1.05-1.25,P<0.01)。
临床怎么用
- 表观遗传年龄加速可能作为房颤风险评估的补充指标,尤其DNAm GrimAge和DNAm PhenoAge。
- 生物学衰老过程可能可干预,不受时间因素限制,为房颤预防提供新思路。
- 目前因果证据不足,暂不推荐常规临床应用表观遗传时钟预测房颤。
局限性
- 观察性设计不能确立因果关系,孟德尔随机化未支持因果关联。
- 仅纳入3个人群队列,结果外推需谨慎。
- 未明确表观遗传年龄加速与房颤关联的具体机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a phenomenon referred to as epigenetic age acceleration (EAA), which may reflect accelerated biological aging. We sought to evaluate for associations between epigenetic age measures and incident AF. METHODS: Measures for 4 epigenetic clocks (Horvath, Hannum, DNA methylation [DNAm] PhenoAge, and DNAm GrimAge) and an epigenetic predictor of PAI-1 (plasminogen activator inhibitor-1) levels (ie, DNAm PAI-1) were determined for study participants from 3 population-based cohort studies. Cox models evaluated for associations with incident AF and results were combined via random-effects meta-analyses. Two-sample summary-level Mendelian randomization analyses evaluated for associations between genetic instruments of the EAA measures and AF. RESULTS: Among 5600 participants (mean age, 65.5 years; female, 60.1%; Black, 50.7%), there were 905 incident AF cases during a mean follow-up of 12.9 years. Unadjusted analyses revealed all 4 epigenetic clocks and the DNAm PAI-1 predictor were associated with statistically significant higher hazards of incident AF, though the magnitudes of their point estimates were smaller relative to the associations observed for chronological age. The pooled EAA estimates for each epigenetic measure, with the exception of Horvath EAA, were associated with incident AF in models adjusted for chronological age, race, sex, and smoking variables. After multivariable adjustment for additional known AF risk factors that could also potentially function as mediators, pooled EAA measures for 2 clocks remained statistically significant. Five-year increases in EAA measures for DNAm GrimAge and DNAm PhenoAge were associated with 19% (adjusted hazard ratio [HR], 1.19 [95% CI, 1.09-1.31]; P<0.01) and 15% (adjusted HR, 1.15 [95% CI, 1.05-1.25]; P<0.01) higher hazards of incident AF, respectively. Mendelian randomization analyses for the 5 EAA measures did not reveal statistically significant associations with AF. CONCLUSIONS: Our study identified adjusted associations between EAA measures and incident AF, suggesting that biological aging plays an important role independent of chronological age, though a potential underlying causal relationship remains unclear. These aging processes may be modifiable and not constrained by the immutable factor of time.
引用
- Roberts JD, Vittinghoff E, Lu AT, et al. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021. PMID: 34587750. doi:10.1161/CIRCULATIONAHA.121.056456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。